PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Diplomat Pharmacy

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Diplomat Specialty Pharmacy Lands on Inc. Magazine’s List of the Fastest Growing Private Companies - Diplomat Pharmacy, Inc. ranks number 1908 on the 2013 Inc. 500|5000 with three-Year sales growth of 199% - DiplomatPharmacy.com
Diplomat Specialty Pharmacy Lands on Inc. Magazine’s List of the Fastest Growing Private Companies

 

NewswireToday - /newswire/ - Flint, MI, United States, 2013/08/22 - Diplomat Pharmacy, Inc. ranks number 1908 on the 2013 Inc. 500|5000 with three-Year sales growth of 199% - DiplomatPharmacy.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

CEO Phil Hagerman, R.Ph., announced today that Diplomat Specialty Pharmacy, the country’s largest independent specialty pharmacy servicing the needs of patients and physicians nationwide, has earned a position for the fifth consecutive year on Inc. Magazine’s seventh annual Inc. 500|5000, an exclusive ranking of the nation's fastest-growing private companies. The Company ranked third in the nation in the list’s health category for revenue, a jump from fourth in 2012, and its three year growth rate was pegged at 199 percent from $377.5 million in 2009 to $1.1 billion in 2012.

“Recognition on the Inc. 5000 list continues to be an important metric in gauging our overall growth,” said Hagerman, who co-founded Diplomat Specialty Pharmacy with his pharmacist father Dale Hagerman immediately following graduation from pharmacy school in 1975. “What is especially meaningful to the Diplomat team is we continue to grow the business and forge relationships with new health care industry partners while achieving sustained customer and physician satisfaction rates above 98 percent.”

With almost 500 jobs created between 2009 and 2012, Diplomat was cited by Inc. magazine in December 2012 as one of nation’s top 100 job creators. Looking forward, Hagerman foresees additional business and job growth.

“Diplomat remains on track to add a total of 1,000 new jobs between 2010 and 2015. We’ll need that increased capacity as projected specialty pharmacy purchases are projected to be 50 percent of the total drug spend by 2018,” said Hagerman.

Hagerman noted that even more important than job growth is Diplomat’s unwavering attention to patient care and its clinical mission to improve patient compliance and adherence as drug therapies grow more complex and costly, and often bring challenging side effects.

“The key to optimal patient compliance and adherence lies with patient education and training, packaging that keeps drugs safe and secure yet is easy for patients to open, side effect management kits, nurse adherence calls for clinical support and guidance, and adaptive technology, whether that be through smart phones, prescription bottles with glow caps or packaging with alarms and reminders,” said Hagerman. “Diplomat is a leader in these areas and we will continue to focus efforts on new approaches to compliance and adherence through our high-tech, high-touch patient strategy.”

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region and other criteria, can be found at inc.com/5000.

"Not all the companies in the Inc. 500 | 5000 are in glamorous industries, but in their fields they are as famous as household name companies simply by virtue of being great at what they do. They are the hidden champions of job growth and innovation, the real muscle of the American economy,” said Inc. Editor Eric Schurenberg.

About the Inc. 500/5000 Methodology

The 2013 Inc. 500|5000 is ranked according to percentage revenue growth when comparing 2009 to 2012. To qualify, companies must have been founded and generating revenue by March 31, 2009. They had to be U.S.-based, privately held, for profit, and independent not subsidiaries or divisions of other companies as of December 31, 2012. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2009 is $100,000; the minimum for 2012 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at inc.com/500.

About Diplomat Specialty Pharmacy

Michigan-based Diplomat Specialty Pharmacy (diplomatpharmacy.com), founded in 1975, serves patients nationwide as the country’s largest independent specialty pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s, Hemophilia/IVIG, Growth Hormone and Psoriasis. Other specialty areas include transplant, fertility and bio-identical hormone therapy. Diplomat’s business model creates unique partnerships around both distribution and services with all industry stakeholders including physicians, patients, group purchasing organizations, hospital systems, retail chains and managed markets, always focused on improving adherence and the patient experience. Learn more about Keeping Patients Healthier…Longer

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Diplomat Pharmacy

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Diplomat Specialty Pharmacy Lands on Inc. Magazine’s List of the Fastest Growing Private Companies

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Kosmerick - DiplomatPharmacy.com 
1-888-720-4450 jkosmerick[.]diplomatpharmacy.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Diplomat Pharmacy securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Diplomat Pharmacy / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)